Nonsense-mediated decay microarray analysis identifies mutations of EPHB2 in human prostate cancer

Nature Genetics

Volumn 36, Issue 9, 2004, Pages 979-983

  Huusko, Pia ^a   Ponciano Jackson, Damaris ^a   Wolf, Maija ^b   Kiefer, Jeff A ^a   Azorsa, David O ^a   Tuzmen, Sukru ^a   Weaver, Don ^a   Robbins, Christiane ^a   Moses, Tracy ^a   Allinen, Minna ^c   Hautaniemi, Sampsa ^d   Chen, Yidong ^c   Elkahloun, Abdel ^c   Basik, Mark ^e   Bova, G Steven ^f   Bubendorf, Lukas ^g   Lugli, Alessandro ^g   Sauter, Guido ^g   Schleutker, Johanna ^h   Ozcelik, Hilmi ⁱ   Elowe, Sabine ⁱ   Pawson, Tony ⁱ   Trent, Jeffrey M ^a   Carpten, John D ^a   Kallioniemi, Olli P ^a,b   Mousses, Spyro ^a   more..

^a TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF TURKU   (Finland)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^d TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^e MCGILL UNIVERSITY   (Canada)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF BASEL   (Switzerland)

^h UNIVERSITY OF TAMPERE   (Finland)

ⁱ MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EPHB2 PROTEIN; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CANCER GENETICS; CELL MIGRATION; CELL STRAIN DU 145; CLONOGENESIS; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA MICROARRAY; EPHB2 GENE; FRAMESHIFT MUTATION; GENE; GENE DELETION; GENE IDENTIFICATION; GENE INACTIVATION; GENE LOSS; GENE MUTATION; GENETIC TRANSFECTION; GROWTH INHIBITION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; MISSENSE MUTATION; NONSENSE MEDIATED DECAY MICROARRAY ANALYSIS; NONSENSE MUTATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE CANCER; RNA DEGRADATION; RNA SPLICING; SOLID TUMOR; SPLICE SITE MUTATION; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; WILD TYPE;

CELL LINE, TUMOR; CODON, NONSENSE; EMETINE; GENES, TUMOR SUPPRESSOR; HUMANS; MALE; MOLECULAR SEQUENCE DATA; MUTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROSTATIC NEOPLASMS; RECEPTOR, EPHB2; RNA STABILITY; TRANSFECTION;

EID: 4444326581     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng1408     Document Type: Article

References (21)

1. Noensie, E.N. & Dietz, H.C. A strategy for disease gene identification through nonsense-mediated mRNA decay inhibition. Nat. Biotechnol. 19, 434-439 (2001).
2. Pollack, J.R. et al. Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nat. Genet. 23, 41-46 (1999).
3. Hyman, E. et al. Impact of DNA amplification on gene expression patterns in breast cancer. Cancer Res. 62, 6240-6245 (2002).
4. Knudson, A.G. Jr. Hereditary cancer, oncogenes, and antioncogenes. Cancer Res. 45, 1437-1443 (1985).
5. Losson, R. & Lacroute, F. Interference of nonsense mutations with eukaryotic messenger RNA stability. Proc. Natl. Acad. Sci. USA 76, 5134-5137 (1979).
6. Culbertson, M.R. RNA surveillance. Unforeseen consequences for gene expression, inherited genetic disorders and cancer. Trends Genet. 15, 74-80 (1999).
7. Gibbs, M. et al. Evidence for a rare prostate cancer-susceptibility locus at chromosome 1p36. Am. J. Hum. Genet. 64, 776-787 (1999).
8. Kullander, K. & Klein, R. Mechanisms and functions of Eph and ephrin signalling. Nat. Rev. Mol. Cell. Biol. 3, 475-486 (2002).
9. Mellitzer, G., Xu, Q. & Wilkinson, D.G. Control of cell behaviour by signalling through Eph receptors and ephrins. Curr. Opin. Neurobiol. 10, 400-408 (2000).
10. Wang, H.U., Chen, Z.F. & Anderson, D.J. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 93, 741-753 (1998).
11. Gale, N.W. et al. Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth-muscle cells. Dev. Biol. 230, 151-160 (2001).
12. Wilkinson, D.G. Multiple roles of EPH receptors and ephrins in neural development. Nat. Rev. Neurosci. 2, 155-164 (2001).
13. Knoll, B. & Drescher, U. Ephrin-As as receptors in topographic projections. Trends Neurosci. 25, 145-149 (2002).
14. Barrios, A. et al. Eph/Ephrin signaling regulates the mesenchymal-to-epithelial transition of the paraxial mesoderm during somite morphogenesis. Curr. Biol. 13, 1571-1582 (2003).
15. Batlle, E. et al. β-Catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB. Cell 111, 251-263 (2002).
16. Elowe, S., Holland, S.J., Kulkarni, S. & Pawson, T. Downregulation of the Rasmitogen-activated protein kinase pathway by the EphB2 receptor tyrosine kinase is required for ephrin-induced neurite retraction. Mol. Cell. Biol. 21, 7429-7441 (2001).
17. DeRisi, J. et al. Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat. Genet. 14, 457-460 (1996).
18. Mousses, S. et al. Gene expression analysis by cDNA microarrays. in Functional Genomics (eds. Livesey, F. & Hunt, S.P.) 113-137 (Oxford University Press, Oxford, 2000).
19. Chen, Y., Dougherty, E. & Bittner, M. Ratio-based decisions and the quantitative analysis of cDNA microarray images. J. Biomed. Optics 2, 364-374 (1997).
20. Chen, Y. et al. Ratio statistics of gene expression levels and applications to microarray data analysis. Bioinformatics 18, 1207-1215 (2002).
21. Monni, O. et al. Comprehensive copy number and gene expression profiling of the 17q23 amplicon in human breast cancer. Proc. Natl. Acad. Sci. USA 98, 5711-5716 (2001).